Adaptations of the IGF System during Malignancy: Human Skeletal Muscle versus the Systemic Environment

Hormone and Metabolic Research

Volumn 35, Issue 11-12, 2003, Pages 667-674

  Foulstone, E J ^a   Savage, P B ^a   Crown, A L ^a   Holly, J M P ^a   Stewart, C E H ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cancer; Myoblast satellite cells

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CELL COUNT; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MUSCLE CANCER; MUSCLE FIBER CULTURE; MYOBLAST; MYOTUBE; PRIORITY JOURNAL; PROTEIN FUNCTION; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL;

ADULT; AGE FACTORS; AGED; BODY WEIGHT; CELLS, CULTURED; CREATINE KINASE; FEMALE; GASTROINTESTINAL NEOPLASMS; GENITAL DISEASES, FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOBLASTS; NEOPLASMS; RADIOIMMUNOASSAY; SURGICAL PROCEDURES, ELECTIVE;

EID: 0347356292     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814159     Document Type: Article

References (30)

1. Calman KC. Cancer and cachexia. Br J Hosp Med 1982; 27: 28-29, 33-34
2. Wilmore DW. Catabolic illness. N Engl J Med 1991; 325: 695-702
3. DeWys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J of Med 1980; 9: 491-497
4. Florini JR, Magri KA, Ewton DZ, James PL, Grindstaff K. Rotwein PS. "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem 1991; 266: 15917-15923
5. Stewart CEH, Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 1996; 76: 1005-1026
6. Wolf RF, Pearlstone DB, Newman E, Heslin MJ, Gonenne A, Burt M, Brennan MF. Growth hormone and insulin reverse net whole body and skeletal muscle protein catabolism in cancer patients. Ann Surg 1992; 216: 280-290
7. Lieberman SA, Butterfield GE, Harrison D, Hoffman AR. Anabolic effects of recombinant insulin-like growth factor-I in cachetic patients with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1994; 78: 404-410
8. Lee PDK, Pivarnik JM, Bukar JG, Muurahainen N, Berry PS, Skolnik PR, Nerad JL, Kudsk KA, Jackson L, Ellis KJ, Gesundheit N. A randomised, placebo-controlled trial of combined insulin-like growth factor-I and low dose growth hormone for wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1996; 81: 2968-2975
9. Douglas RG, Gluckman PD, Breier BH, McCall JL, Parry B, Shaw JHF. Effects of recombinant IGF-I on protein and glucose metabolism in rTNF-infused lambs. Am J Physiol 1991; 261: E606-E612
10. Ng E-H, Rock CS, Lazarus DD, Stiano-Coico L, Moldawer LL, Lowry SF. Insulin-like growth factor-I preserves host lean tissue mass in cancer cachexia. Am J Physiol 1992; 262: R426-R431
11. Cooper RN, Tajbakhsh S, Mouly V, Cossu G, Buckingham M, Butler-Browne GS. In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J Cell Sci 1999; 112: 2895-2901
12. Crown AL, He XL, Holly JMP, Lightman SL, Stewart CEH. Characterisation of the IGF system in a primary adult human skeletal muscle cell model, and comparison of the effects of insulin and IGF-I on protein metabolism. J Endocrinol 2000; 67: 403-415
13. Henry RR, Ciardaldi TP, Abrams-Carter L, Mudaliar S, Park KS, Nikoulina SE. Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin dependent diabetes mellitus subjects. J Clin Invest 1996; 98: 1231-1236
14. Khaled MA, McCutcheon MJ, Reddy S, Pearman PL, Hunter GR, Weinsier RL. Electrical impedance in assessing human body composition: the BIA method. Am J Clin Nutr 1988; 47: 789-792
15. Blau HM, Webster C. Isolation and characterisation of human muscle cells. Proc Natl Acad Sci USA 1981; 78: 5623-5627
16. Foulstone EJ, Savage PB, Crown AL, Holly JMP, Stewart CEH. Role of insulin-like growth factor binding protein-3 (IGFBP-3) in the differentiation of primary human adult skeletal myoblasts. J Cell Physiol 2003; 195: 70-79
17. Cheetham TD, Holly JM, Baxter RC, Meadows K, Jones J, Taylor AM, Dunger DB. The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus. J Endocrinol 1998; 57: 81-87
18. Elmlinger MW, Dengler T, Weinstock C, Kuehnel W. Endocrine alterations in the aging male. Clin Chem Lab Med 2003; 41: 934-941
19. Gelato MC, Frost RA. IGFBP-3. Functional and structural implications in aging and wasting syndromes. Endocrine 1997; 7: 81-85
20. Renault V, Piron-Hamelin G, Forestier C, DiDonna S, Decary S, Hentati F, Saillant G, Butler-Browne GS, Mouly V. Skeletal muscle regeneration and the mitotic clock. Exp Gerontol 2000; 35: 711-719
21. Lorite MJ, Smith HJ, Arnold JA, Morris A, Thompson MG, Tisdale MJ. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF). Br J Cancer 2001; 85: 297-302
22. Smith HJ, Tisdale MJ. Induction of apoptosis by a cachetic-factor in murine myotubes and inhibition by eicosapentaenoic acid. Apoptosis 2003; 8: 161-169
23. Wang Z, Corey E, Hass GM, Higano CS, True LD, Wallace D Jr, Tisdale MJ, Vessella RL. Expression of the human cachexia-associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia. Int J Cancer 2003; 105: 123-129
24. Schultz E, Albright DJ, Jaryszak DL, David TL. Survival of satellite cells in whole muscle transplants. Anatomical Record 1988; 222: 12-17
25. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM, Mulligan RC. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999; 401: 390-394
26. Carlson BM, Dedkov EI, Borisov AB, Faulkner JA. Skeletal muscle regeneration in very old rats. J Gerontol A Biol Sci Med Sci 2001; 56: B224-233
27. Johnson BJ, White ME, Hathaway MR, Dayton WR. Decreased steady-state insulin-like binding protein-3 (IGFBP-3) mRNA level is associated with differentiation of cultured porcine myogenic cells. J Cell Physiol 1999; 179: 237-243
28. Gill ZP, Perks CM, Newcomb PV, Holly JM. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. J Biol Chem 1997; 272: 25 602-25 607
29. Perks CM, McCraig C, Holly JM. Differential insulin-like growth factor (IGF)-independent interactions of IGF binding protein-3 and IGF binding protein-5 on apoptosis in human breast cancer cells. Involvement of the mitochondria. J Cell Biochem 2001; 80: 248-258
30. Spagnoli A, Hwa V, Horton WA, Lunstrum GP, Roberts CT Jr, Chiarelli F, Torello M, Rosenfeld RG. Antiproliferative effects of insulin-like growth factor-binding protein-3 in mesenchymal chondrogenic cell line RCJ3.1C5.18. Relationship to differentiation stage. J Biol Chem 2001; 276: 5533-5540